From the Chair
From the Chair
Advertisement
Ajay K. Singh, MBBS, FRCP, MBAIgA Nephropathy | June 4, 2024
IgA nephropathy (IgAN) is on the cusp of a transformational change in its treatment.
Read More
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | April 12, 2024
APRIL has emerged as a critical factor in the pathogenesis of IgAN and is the focus of several clinical development programs.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 8, 2024
The benefit-risk ratio and considerations about unmet need are worth considering.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
SGLT2i therapy is contraindicated in patients with type 1 diabetes mellitus (T1DM) who have CKD.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
The first part of the dialysis moonshot is to prevent the need for dialysis.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
Measuring eGFR and UACR is a key component of guideline-directed medical therapy for patients with CKD from type 2 diabetes.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
The most important patients who should receive treatment with SGLT2 inhibitors are those with CKD and type 2 diabetes.
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
Sodium-glucose transport protein 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, block SGLT2 cotransporters in the ...
Ajay K. Singh, MBBS, FRCP, MBAChronic Kidney Disease | February 5, 2024
From the Chair ...
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | February 5, 2024
From the Chair ...
Ajay K. Singh, MBBS, FRCP, MBAChronic Kidney Disease | February 5, 2024
Managing blood pressure is probably the most important intervention that a nephrologist pursues in slowing kidney ...
Ajay K. Singh, MBBS, FRCP, MBAChronic Kidney Disease | February 5, 2024
Approximately 221 million people worldwide have been diagnosed with infection from SARS-CoV-2, the virus that causes ...
Ajay K. Singh, MBBS, FRCP, MBAChronic Kidney Disease | February 5, 2024
The approval by the US FDA on August 23, 2021, of difelikefalin (marketed as Korsuva™ by Cara Therapeutics) is a major ...
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | August 23, 2021
In a thought-provoking Viewpoint article in JAMA Surgery1, Arthur Matas, MD, makes the case for introducing a regulated ...
Ajay K. Singh, MBBS, FRCP, MBAFrom the Chair | August 28, 2023
Editor's Note: ...
Advertisement
Advertisement
Advertisement
Latest News

July 18, 2024